🌟 Precision Medicine Revolution: Nicole Junkermann’s investment in Alto Neuroscience is reshaping drug development. Their AI-driven biomarker platform

🌟 Precision Medicine Revolution: Nicole Junkermann’s investment in Alto Neuroscience is reshaping drug development. Their AI-driven biomarker platform